Results 21 to 30 of about 42,499 (267)

Ethnic differences in health related quality of life for patients with type 2 diabetes [PDF]

open access: yes, 2014
Background: The objective of this study was to investigate the association between ethnicity and health related quality of life (HRQoL) in patients with type 2 diabetes. Methods: The EuroQol EQ-5D measure was administered to 1,978 patients with type 2
Stavros Petrou   +12 more
core   +1 more source

Changes in the quality of life in severely disabled people following provision of powered indoor/outdoor chairs

open access: yes, 2003
Purpose:To determine the benefits for patients who received an Electric Powered Indoor/outdoor Chair (EPIOC) and to quantify their perceived changes to their quality of life.
Davies, A   +5 more
core   +1 more source

Dimensions of quality of life in patients with heart failure and sarcopenia: a scoping review protocol

open access: yesGeriatrics, Gerontology and Aging
Objective: To map the dimensions of quality of life in patients with heart failure (HF) and sarcopenia. Methods: The scoping review will adhere to the JBI Manual for Evidence Synthesis methodology and will be reported following the Preferred Reporting ...
Valéria Gonçalves da Silva   +4 more
doaj   +1 more source

Euthanasia, religiosity and the valuation of health states: results from an Irish EQ5D5L valuation study and their implications for anchor values

open access: yesHealth and Quality of Life Outcomes, 2018
Background The Quality Adjusted Life Year influences the allocation of significant amounts of healthcare resources. Despite this surprisingly little research effort has been devoted to analysing how beliefs and attitudes to hastening death influence ...
Luke Barry   +6 more
doaj   +1 more source

A new Patient‐Reported Outcome Scale to assess autoimmune Encephalitis: PROSE

open access: yesAnnals of Neurology, EarlyView.
Objective Autoimmune encephalitis (AIE) has long‐lasting effects. Generic clinical assessment‐scales insufficiently capture disease‐specific sequelae. Patient‐reported outcome measures (PROMs) assess outcomes important to patients, ensuring relevance in the clinic and trials.
Juliette Brenner   +24 more
wiley   +1 more source

Transitioning between the EQ-5D youth and adult descriptive systems in a group of adolescents

open access: yesJournal of Patient-Reported Outcomes
Purpose To investigate whether the same health state results in the same distribution of responses on the EQ-5D youth and adult descriptive systems. Methods Adolescents aged 13–18 years with a range of health conditions and from the general school going ...
Janine Verstraete   +5 more
doaj   +1 more source

Responsiveness of the EuroQoL 5-Dimension (EQ-5D) questionnaire in patients with spondyloarthritis

open access: yesBMC Musculoskeletal Disorders, 2021
Background Spondyloarthritis (SpA) has a significant impact on patients’ quality of life due to functional impairments. Generic health instruments like the EuroQoL 5-dimension (EQ-5D) is important for cost-utility analysis of health care interventions ...
Helen Hoi Lun Tsang   +5 more
doaj   +1 more source

Arthroscopic Partial Repair and Arthroscopic Debridement Improve Pain and Functional Outcomes in Older Patients With Massive Irreparable Rotator Cuff Tears: A Systematic Review

open access: yesArthroscopy, Sports Medicine, and Rehabilitation, EarlyView.
Purpose To evaluate the current evidence on patient‐reported outcomes and complications after arthroscopic partial repair and arthroscopic debridement for massive irreparable rotator cuff tears (MIRCTs) in patients aged 65 years or older. Methods A systematic search of MEDLINE, Embase, and Cochrane Library databases was conducted through September 2025
Dave Osinachukwu Duru   +4 more
wiley   +1 more source

Mapping of the EQ-5D index from clinical outcome measures and demographic variables in patients with coronary heart disease

open access: yes, 2010
The official published version of the article can be found at the link below.Background: The EuroQoL 5D (EQ-5D) is a questionnaire that provides a measure of utility for cost-effectiveness analysis.
Dyer, Matthew T.   +19 more
core   +2 more sources

Considerations for drug trials in hypertrophic cardiomyopathy

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy